144: Filer Information
Filer CIK | 0001757584 |
Filer CCC | XXXXXXXX |
Is this a LIVE or TEST Filing? | LIVE TEST |
Submission Contact Information | |
Name | |
Phone | |
E-Mail Address |
Form 144 Filer Information |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 | |
FORM 144 |
Filer CIK | 0001757584 |
Filer CCC | XXXXXXXX |
Is this a LIVE or TEST Filing? | LIVE TEST |
Submission Contact Information | |
Name | |
Phone | |
E-Mail Address |
Name of Issuer | CVS HEALTH Corp |
SEC File Number | 001-01011 |
Address of Issuer | ONE CVS DR. WOONSOCKET RHODE ISLAND 02895 |
Phone | 4017651500 |
Name of Person for Whose Account the Securities are To Be Sold | Clark James David |
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account
the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given
as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales
for the account of the person filing this notice.
| |
Relationship to Issuer | Officer |
Title of the Class of Securities To Be Sold | Name and Address of the Broker | Number of Shares or Other Units To Be Sold | Aggregate Market Value | Number of Shares or Other Units Outstanding | Approximate Date of Sale | Name the Securities Exchange |
---|---|---|---|---|---|---|
COMMON | ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005 | 25759 | 1929929.50 | 1300000000 | 08/03/2023 | NYSE |
Title of the Class | Date you Acquired | Nature of Acquisition Transaction | Name of Person from Whom Acquired | Is this a Gift? | Date Donor Acquired | Amount of Securities Acquired | Date of Payment | Nature of Payment * |
---|---|---|---|---|---|---|---|---|
COMMON | 04/01/2020 | RESTRICTED STOCK | ISSUER | 597 | 04/01/2020 | COMPENSATION | ||
COMMON | 04/03/2021 | RESTRICTED STOCK | ISSUER | 577 | 04/03/2021 | COMPENSATION | ||
COMMON | 04/01/2022 | RESTRICTED STOCK | ISSUER | 1103 | 04/01/2022 | COMPENSATION | ||
COMMON | 04/01/2020 | RESTRICTED STOCK | ISSUER | 3439 | 04/01/2020 | COMPENSATION | ||
COMMON | 04/01/2021 | RESTRICTED STOCK | ISSUER | 3445 | 04/01/2021 | COMPENSATION | ||
COMMON | 04/01/2023 | RESTRICTED STOCK | ISSUER | 555 | 04/01/2023 | COMPENSATION | ||
COMMON | 04/01/2021 | RESTRICTED STOCK | ISSUER | 5039 | 04/01/2021 | COMPENSATION | ||
COMMON | 04/01/2021 | PERFORMANCE SHARES | ISSUER | 2479 | 04/01/2021 | COMPENSATION | ||
COMMON | 02/28/2020 | PERFORMANCE SHARES | ISSUER | 173 | 02/28/2020 | COMPENSATION | ||
COMMON | 02/28/2020 | RESTRICTED STOCK | ISSUER | 352 | 02/28/2020 | COMPENSATION | ||
COMMON | 02/28/2020 | RESTRICTED STOCK | ISSUER | 832 | 02/28/2020 | COMPENSATION | ||
COMMON | 02/28/2021 | RESTRICTED STOCK | ISSUER | 1236 | 02/28/2021 | COMPENSATION | ||
COMMON | 04/01/2021 | PERFORMANCE SHARES | ISSUER | 349 | 04/01/2021 | COMPENSATION | ||
COMMON | 02/28/2021 | RESTRICTED STOCK | ISSUER | 1494 | 02/28/2021 | COMPENSATION | ||
COMMON | 01/01/2018 | ESPP | ISSUER | 201 | 01/01/2018 | COMPENSATION | ||
COMMON | 01/01/2017 | ESPP | ISSUER | 368 | 01/01/2017 | COMPENSATION | ||
COMMON | 01/01/2016 | ESPP | ISSUER | 295 | 01/01/2016 | COMPENSATION | ||
COMMON | 01/01/2015 | ESPP | ISSUER | 272 | 01/01/2015 | COMPENSATION | ||
COMMON | 01/01/2014 | ESPP | ISSUER | 362 | 01/01/2014 | COMPENSATION | ||
COMMON | 01/01/2013 | ESPP | ISSUER | 465 | 01/01/2013 | COMPENSATION | ||
COMMON | 01/01/2012 | ESPP | ISSUER | 454 | 01/01/2012 | COMPENSATION | ||
COMMON | 01/01/2011 | ESPP | ISSUER | 215 | 01/01/2011 | COMPENSATION |
Nothing to Report |
Remarks | ESPP BREAKDOWN Shares sold have been rounded to the nearest whole number. 2018 Shares - 8/2/2018 20.458 6/29/2018 144.344 5/4/2018 19.666 2/5/2018 16.290 2017 Shares - 12/29/2017 109.259 11/6/201716.834 8/4/201714.598 6/30/2017201.513 5/2/201712.684 2/3/2017 13.593 2016 Shares - 12/30/2016 131.247 11/4/2016 9.928 8/2/2016 8.332 6/30/2016 129.914 5/3/2016 7.281 2/3/2016 7.853 2015 Shares - 12/31/2015 113.728 11/3/2015 5.781 8/4/2015 5.235 6/30/2015 136.465 5/5/2015 5.272 2/3/2015 5.268 2014 Shares - 12/31/2014 139.853 11/4/2014 4.393 8/4/2014 4.819 6/30/2014 204.056 5/5/2014 4.174 2/4/2014 4.730 2013 Shares - 12/31/2013 245.155 11/4/2013 3.201 8/5/2013 3.207 6/30/2013 207.730 5/6/2013 2.603 2/4/2013 2.938 2012 Shares - 12/31/2012 210.231 11/2/2012 1.584 8/3/2012 3.511 6/30/2012 238.840 2011 Shares - 12/31/2011 214.689 Restricted/Performance Shares - Grouping these trades by Grant numbers using earliest date grant was given. |
Date of Notice | 08/03/2023 |
ATTENTION: | |
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date. | |
Signature | /s/ James D. Clark |
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001) |